# Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases

> **NCT02040116** · PHASE4 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 19 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Rituximab Infusion

## Key facts

- **NCT ID:** NCT02040116
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2018-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02040116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02040116, "Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02040116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*